J. Pearle

发表

Intravenous MN-221, a Novel, Highly Selective Beta2-Adrenergic Receptor Agonist, Improves Lung Function in Stable Moderate to Severe Chronic Obstructive Pulmonary Disease Patients

A. Dunton, Y. Iwaki, J. Pearle, 2010 .

Exercise performance and functional impairment in asbestos-exposed workers.

J. Pearle, 1981, Chest.

Flexible fiberoptic bronchoscopy--an analysis of proficiency.

J. Pearle, 1980, Chest.

Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.

A. Anzueto, M. Niederman, M. Restrepo, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER)

E. Kerwin, G. Feldman, G. Georges, 2021, COPD.

Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology.

P. DePetrillo, G. Ferguson, C. Reisner, 2018, Pulmonary pharmacology & therapeutics.

Ventilatory control and the obesity hypoventilation syndrome.

R. V. Lourenço, E. Onal, M. Lopata, 1979, The American review of respiratory disease.

IMPROVEMENT OF LUNG FUNCTION WITH COADMINISTERED FORMOTEROL AND TIOTROPIUM, REGARDLESS OF SMOKING STATUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

D. Tashkin, J. Pearle, S. Varghese, 2008 .

Smoking and duration of asbestos exposure in the production of functional and roentgenographic abnormalities in shipyard workers.

J. Pearle, 1982, Journal of occupational medicine. : official publication of the Industrial Medical Association.

Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD

D. Tashkin, D. Iezzoni, J. Pearle, 2009, COPD.

Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

E. Kerwin, R. Rodríguez-Roisín, L. Fabbri, 2016, Respiratory Research.

Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.

A. Sharafkhaneh, C. Côté, S. Spangenthal, 2009, Pulmonary pharmacology & therapeutics.

Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

E. Kerwin, C. Reisner, P. Darken, 2018, International journal of chronic obstructive pulmonary disease.